The study shows that disease severity and poor prognosis in ATTR-CM are associated with elevated levels of mid-regional ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Numerous potential treatments for neurological conditions, including autism spectrum disorders, have worked well in lab mice but then disappointed in humans. What would help is a non-invasive, ...

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon make it possible to more precisely match patients with their optimal therapy.

ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscribed $4.9M ...

The field of neurological disease research is rapidly evolving, with protein biomarkers advancing our understanding, improving diagnosis, and guiding treatment for disorders such as Alzheimer's ...

Traditional approaches for detecting Alzheimer’s disease (AD) that rely on examining the brain for amyloid plaques have limitations in accuracy and early detection. Although the industry has ...

As multicancer early detection research scales, generating sensitive and reproducible biomarker data across large studies remains a critical challenge. While advances in genomic and proteomic tools ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

From pesticides in our food to hormone disruptors in our kitchen pans, modern life is saturated with chemicals, exposing us to unknown long-term health impacts. One of the surest routes to quantifying ...